Skip Navigation



Human Molecular Genetics Advance Access published online on December 1, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddi026
© 2004 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
14/2/295    most recent
ddi026v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Esapa, C. T.
Right arrow Articles by Blake, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esapa, C. T.
Right arrow Articles by Blake, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Article

Fukutin-related protein (FKRP) mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells

Christopher T. Esapa 1, R.A. Jeffrey McIlhinney 2, and Derek J. Blake 3*

1 Department of Pharmacology, University of Oxford, Oxford, UK
2 Medical Research Council Anatomical Neuropharmacology Unit, University of Oxford, Oxford, UK
3 Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK

* To whom correspondence should be addressed.
Derek J. Blake, E-mail: derek.blake{at}pharm.ox.ac.uk


  Abstract

Mutations in the gene encoding fukutin-related protein (FKRP) cause a spectrum of diseases including congenital muscular dystrophy type 1C (MDC1C), limb girdle muscular dystrophy 2I (LGMD2I) and congenital muscular dystrophies with brain malformations and mental retardation. Whilst these diseases are associated with abnormal dystroglycan processing the cellular consequences of the idiosyncratic FKRP mutations have not been determined. Here we show in cultured cells that FKRP mutants associated with the more severe disease phenotypes (S221R, A455D, P448L) are retained in the endoplasmic reticulum (ER) whereas the wild-type protein and the mutant, L276I that causes LGMD2I are found predominantly in the Golgi apparatus. The ER-retained proteins have a shorter half-life than wild-type FKRP and are preferentially degraded by the proteasome. Furthermore, calnexin binds preferentially to the ER-retained mutants suggesting that it may participate in the quality control pathway for FKRP. These data provide the first evidence that ER-retention of mutant FKRP may play a role in the pathogenesis of congenital muscular dystrophy and potentially explain why the allelic disorder LGMD2I is milder because the mutated protein is able to reach the Golgi apparatus.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
S. Gastaldello, S. D'Angelo, S. Franzoso, M. Fanin, C. Angelini, R. Betto, and D. Sandona
Inhibition of Proteasome Activity Promotes the Correct Localization of Disease-Causing {alpha}-Sarcoglycan Mutants in HEK-293 Cells Constitutively Expressing {beta}-, {gamma}-, and {delta}-Sarcoglycan
Am. J. Pathol., July 1, 2008; 173(1): 170 - 181.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. T. Atlason, M. L. Garside, E. Meddows, P. Whiting, and R. A. J. McIlhinney
N-Methyl-D-aspartate (NMDA) Receptor Subunit NR1 Forms the Substrate for Oligomeric Assembly of the NMDA Receptor
J. Biol. Chem., August 31, 2007; 282(35): 25299 - 25307.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Beedle, P. M. Nienaber, and K. P. Campbell
Fukutin-related Protein Associates with the Sarcolemmal Dystrophin-Glycoprotein Complex
J. Biol. Chem., June 8, 2007; 282(23): 16713 - 16717.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. T. Esapa, A. Waite, M. Locke, M. A. Benson, M. Kraus, R.A. J. McIlhinney, R. V. Sillitoe, P. W. Beesley, and D. J. Blake
SGCE missense mutations that cause myoclonus-dystonia syndrome impair {varepsilon}-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA
Hum. Mol. Genet., February 1, 2007; 16(3): 327 - 342.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-W. Franzke, C. Has, C. Schulte, L. Huilaja, K. Tasanen, M. Aumailley, and L. Bruckner-Tuderman
C-terminal Truncation Impairs Glycosylation of Transmembrane Collagen XVII and Leads to Intracellular Accumulation
J. Biol. Chem., October 6, 2006; 281(40): 30260 - 30268.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
E. Mercuri, H. Topaloglu, M. Brockington, A. Berardinelli, A. Pichiecchio, F. Santorelli, M. Rutherford, B. Talim, E. Ricci, T. Voit, et al.
Spectrum of Brain Changes in Patients With Congenital Muscular Dystrophy and FKRP Gene Mutations
Arch Neurol, February 1, 2006; 63(2): 251 - 257.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.